Cardiorenal benefits of finerenone: protecting kidney and heart
AbstractPersons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with renin-angiotensin system blockers and sodium-glucose cotransporter type 2 inhibitors. Overactivation of mineralocorticoid receptors plays a...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2023-12-01
|
| סדרה: | Annals of Medicine |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2171110 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|